Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Gut|August 28, 2025
Global consensus statement on the management of pregnancy in inflammatory bowel diseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
The American Journal of Gastroenterology|August 27, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Journal of Crohn'S & Colitis|September 7, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
The American Journal of Gastroenterology|June 15, 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate-Severe Crohn's Disease: Results From the US VICTORY ConsortiumParambir S Dulai, Siddharth Singh, Xiaoqian Jiang, et al.
Alimentary Pharmacology & Therapeutics|December 24, 2019
A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's diseaseParambir S Dulai, Aurelien Amiot, Laurent Peyrin-Biroulet, et al.
Alimentary Pharmacology & Therapeutics|July 14, 2020
Comparative safety and effectiveness of vedolizumab to tumour necrosis factor antagonist therapy for Crohn's diseaseMatthew Bohm, Ronghui Xu, Yiran Zhang, et al.
Crohn'S & Colitis 360|February 13, 2023
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center ExperienceGuilherme Piovezani Ramos, Badr Al-Bawardy, Manuel Bonfim Braga Neto, et al.
Inflammatory Bowel Diseases|May 23, 2018
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel DiseaseEugenia Shmidt, Gursimran Kochhar, Justin Hartke, et al.
Pageof 16